Company logo

CERS - Cerus Corporation

NASDAQ -> Healthcare -> Biotechnology
Concord, United States
Type: Equity

CERS price evolution
CERS
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $13.36 $19.16 $22.43 $29.39
Short term investments $54.2 $61.62 $63.87 $67.08
Net receivables $35.5 $24.55 $22.18 $25.24
Inventory $59.37 $63.95 $40.61 $36.61
Total current assets $144.44 $150.94 $150.94 $162.22
Long term investments
Property, plant & equipment $19.35 $20.28 $22.52 $23.14
Goodwill & intangible assets $1.32 $1.32 $1.32 $1.32
Total noncurrent assets $53.31 $54.91 $47.92 $47.12
Total investments $54.2 $61.62 $63.87 $67.08
Total assets $197.75 $205.84 $198.86 $209.34
Current liabilities
Accounts payable $23.84 $38.52 $37.49 $36.44
Deferred revenue $2 $0.94 $1.36 $1.69
Short long term debt $22.45 $21.05 $18.72 $20.16
Total current liabilities $67.52 $80.12 $75.08 $77.57
Long term debt $73.55 $73.87 $69.29 $69.79
Total noncurrent liabilities $76.78 $76.7 $72.09 $72.2
Total debt $96 $94.92 $88.01 $89.94
Total liabilities $144.3 $156.82 $147.17 $149.77
Shareholders' equity
Retained earnings -$1044.61 -$1043.28 -$1036.02 -$1022.74
Other shareholder equity -$1.27 -$2.23 -$2.43 -$2.24
Total shareholder equity $52.65 $48.17 $50.82 $58.63
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $13.36 $37.36 $51.04 $38.9
Short term investments $54.2 $66.57 $80.6 $97
Net receivables $35.5 $34.43 $25.13 $21.17
Inventory $59.37 $29 $26.79 $23.25
Total current assets $144.44 $170.14 $187.1 $183.43
Long term investments
Property, plant & equipment $19.35 $23.48 $25.18 $26.99
Goodwill & intangible assets $1.32 $1.32 $1.32 $1.32
Total noncurrent assets $53.31 $47.95 $50.4 $37.98
Total investments $54.2 $66.57 $80.6 $97
Total assets $197.75 $218.09 $237.5 $221.41
Current liabilities
Accounts payable $23.84 $33 $35.61 $24.21
Deferred revenue $2 $0.59 $0.67 $0.58
Short long term debt $22.45 $58.26 $16.6 $10.43
Total current liabilities $67.52 $117.06 $78.56 $59.97
Long term debt $73.55 $13.64 $70.98 $56.46
Total noncurrent liabilities $76.78 $32.47 $73.33 $57.63
Total debt $96 $87.24 $87.59 $66.89
Total liabilities $144.3 $150.48 $151.88 $117.61
Shareholders' equity
Retained earnings -$1044.61 -$1007.12 -$964.34 -$909.97
Other shareholder equity -$1.27 -$2.79 -$0.15 $0.67
Total shareholder equity $52.65 $67.61 $84.62 $103.81
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $53.34 $47.25 $47.73 $38.48
Cost of revenue $20.81 $17.96 $17.52 $13.69
Gross Profit $32.53 $29.3 $30.21 $24.79
Operating activities
Research & development $14.29 $16.78 $19.18 $17.38
Selling, general & administrative $17.27 $16.16 $20.54 $21.55
Total operating expenses $31.56 $34.54 $41.85 $38.94
Operating income $0.98 -$5.24 -$11.64 -$14.15
Income from continuing operations
EBIT $0.97 -$4.83 -$11 -$13.93
Income tax expense $0.07 $0.08 $0.1 $0.08
Interest expense $2.23 $2.36 $2.18 $1.61
Net income
Net income -$1.33 -$7.27 -$13.28 -$15.62
Income (for common shares) -$1.33 -$7.27 -$13.28 -$15.62
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $186.8 $188.31 $159.52 $114.25
Cost of revenue $69.97 $74.95 $63.48 $41.16
Gross Profit $116.83 $113.36 $96.04 $73.09
Operating activities
Research & development $67.64 $64.11 $63.69 $64.41
Selling, general & administrative $75.52 $83.33 $81.29 $67.02
Total operating expenses $146.88 $147.44 $144.98 $131.43
Operating income -$30.05 -$34.08 -$48.94 -$58.33
Income from continuing operations
EBIT -$28.78 -$36.46 -$49.13 -$55.83
Income tax expense $0.33 $0.49 $0.32 $0.28
Interest expense $8.39 $5.83 $4.92 $3.75
Net income
Net income -$37.49 -$42.78 -$54.37 -$59.86
Income (for common shares) -$37.49 -$42.78 -$54.37 -$59.86
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$1.33 -$7.27 -$13.28 -$15.62
Operating activities
Depreciation $1.39 $1.18 $1.23 $1.11
Business acquisitions & disposals
Stock-based compensation $4.9 $3.98 $5.72 $5.67
Total cash flows from operations -$15.18 -$10.49 -$9 -$8.5
Investing activities
Capital expenditures $0.01 -$2.63 -$0.44 -$1.52
Investments $8.21 $2.36 $2.77 -$0.12
Total cash flows from investing $8.22 -$0.28 $2.33 -$1.65
Financing activities
Dividends paid
Sale and purchase of stock -$0.17 $0.43 $0.49
Net borrowings $1.22 $7.17 -$0.11 $1.64
Total cash flows from financing $1.18 $7.6 -$0.17 $2.06
Effect of exchange rate -$0.02 -$0.11 -$0.12 $0.12
Change in cash and equivalents -$5.8 -$3.27 -$6.96 -$7.97
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$37.49 -$42.78 -$54.37 -$59.86
Operating activities
Depreciation $4.91 $4.56 $4.57 $4.46
Business acquisitions & disposals
Stock-based compensation $20.27 $24.46 $23.57 $18.03
Total cash flows from operations -$43.17 -$25.61 -$33.92 -$40.74
Investing activities
Capital expenditures -$4.6 -$2 -$0.91 -$1.61
Investments $13.22 $10.46 $13.6 -$47.94
Total cash flows from investing $8.62 $8.46 $12.69 -$49.56
Financing activities
Dividends paid
Sale and purchase of stock $0.75 $3.98 $12.11 $88.28
Net borrowings $9.92 $0.21 $21.18 $3.5
Total cash flows from financing $10.67 $4.19 $34.29 $91.78
Effect of exchange rate -$0.13 -$0.73 -$0.92
Change in cash and equivalents -$24 -$13.69 $12.14 $1.48
Fundamentals
Market cap $342.56M
Enterprise value $425.20M
Shares outstanding 181.25M
Revenue $186.80M
EBITDA -$23.87M
EBIT -$28.78M
Net Income -$37.49M
Revenue Q/Q 3.94%
Revenue Y/Y -0.81%
P/E ratio -9.14
EV/Sales 2.28
EV/EBITDA -17.81
EV/EBIT -14.78
P/S ratio 1.83
P/B ratio 6.35
Book/Share 0.30
Cash/Share 0.07
EPS -$0.21
ROA -18.47%
ROE -71.32%
Debt/Equity 2.74
Net debt/EBITDA -5.49
Current ratio 2.14
Quick ratio 1.26